Properties
Description
NU 6102 is an CDK kinase inhibitor that disrupts cell division processes. It targets Cdk1/cyclin B, CDK2/cyclin A3, CDK4, and DYRK1A.
Molecular Formula
C18H22N6O3S
Targets
Cdk1/cyclin B: 9.5 nM; CDK2/cyclin A3: 5.4 nM; CDK4: 1.6 μM; DYRK1A: 0.9 μM
Identity
Confirmed by NMR/HPLC/MS.
Applications
NU 6102 can be used to investigate the selective inhibition of CDK2 and its implications in cancer therapy.